Global Chimeric Antigen Receptor Cell Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Global Chimeric Antigen Receptor Cell Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Chimeric Antigen Receptor Cell Therapy Market Overview
1.1 Product Overview and Scope of Chimeric Antigen Receptor Cell Therapy
1.2 Classification of Chimeric Antigen Receptor Cell Therapy by Types
1.2.1 Global Chimeric Antigen Receptor Cell Therapy Revenue Comparison by Types (2019-2024)
1.2.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Types in 2018
1.2.3 Monotherapy
1.2.4 Combination Therapy
1.3 Global Chimeric Antigen Receptor Cell Therapy Market by Application
1.3.1 Global Chimeric Antigen Receptor Cell Therapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Acute Leukemia
1.3.3 Non-hodgkin's Lymphoma
1.3.4 Multiple Myeloma
1.3.5 Transplant Rejection
1.3.6 Other
1.4 Global Chimeric Antigen Receptor Cell Therapy Market by Regions
1.4.1 Global Chimeric Antigen Receptor Cell Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Chimeric Antigen Receptor Cell Therapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Chimeric Antigen Receptor Cell Therapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chimeric Antigen Receptor Cell Therapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Chimeric Antigen Receptor Cell Therapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chimeric Antigen Receptor Cell Therapy Status and Prospect (2014-2024)
1.5 Global Market Size of Chimeric Antigen Receptor Cell Therapy (2014-2024)
2 Manufacturers Profiles
2.1 Amgen Inc
2.1.1 Business Overview
2.1.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 Autolus Therapeutics Plc
2.2.1 Business Overview
2.2.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 Beijing Immunochina Medical Science & Technology Co Ltd
2.3.1 Business Overview
2.3.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bellicum Pharmaceuticals Inc
2.4.1 Business Overview
2.4.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bristol-Myers Squibb Co
2.5.1 Business Overview
2.5.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 bluebird bio Inc
2.6.1 Business Overview
2.6.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.7 CARsgen Therapeutics Ltd
2.7.1 Business Overview
2.7.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.8 Celgene Corp
2.8.1 Business Overview
2.8.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.9 Cell Medica Ltd
2.9.1 Business Overview
2.9.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.10 Cellular Biomedicine Group Inc
2.10.1 Business Overview
2.10.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.11 Celularity Inc
2.11.1 Business Overview
2.11.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.12 Celyad SA
2.12.1 Business Overview
2.12.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.13 Daiichi Sankyo Co Ltd
2.13.1 Business Overview
2.13.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.14 Fosun Pharmaceutical AG
2.14.1 Business Overview
2.14.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.15 Gilead Sciences Inc
2.15.1 Business Overview
2.15.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.16 Guangzhou Anjie Biomedical Technology Co Ltd
2.16.1 Business Overview
2.16.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.17 Hangzhou Converd Co Ltd
2.17.1 Business Overview
2.17.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.18 Hebei Senlang Biotechnology Inc Ltd
2.18.1 Business Overview
2.18.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.19 HRAIN Biotechnology Co Ltd
2.19.1 Business Overview
2.19.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.20 Juno Therapeutics Inc
2.20.1 Business Overview
2.20.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.21 Kite Pharma Inc
2.21.1 Business Overview
2.2.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.22 Nanjing Legend Biotech Co Ltd
2.22.1 Business Overview
2.22.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.23 NantKwest Inc
2.23.1 Business Overview
2.23.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.24 Nkarta Inc
2.24.1 Business Overview
2.24.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.25 Novartis AG
2.25.1 Business Overview
2.25.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.26 Ono Pharmaceutical Co Ltd
2.26.1 Business Overview
2.26.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
2.27.1 Business Overview
2.27.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.28 Sorrento Therapeutics Inc
2.28.1 Business Overview
2.28.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.29 Takara Bio Inc
2.29.1 Business Overview
2.29.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.29.2.1 Product A
2.29.2.2 Product B
2.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global Chimeric Antigen Receptor Cell Therapy Market Competition, by Players
3.1 Global Chimeric Antigen Receptor Cell Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Chimeric Antigen Receptor Cell Therapy Players Market Share
3.2.2 Top 10 Chimeric Antigen Receptor Cell Therapy Players Market Share
3.3 Market Competition Trend
4 Global Chimeric Antigen Receptor Cell Therapy Market Size by Regions
4.1 Global Chimeric Antigen Receptor Cell Therapy Revenue and Market Share by Regions
4.2 North America Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
4.5 South America Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
5 North America Chimeric Antigen Receptor Cell Therapy Revenue by Countries
5.1 North America Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2014-2019)
5.2 USA Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
6 Europe Chimeric Antigen Receptor Cell Therapy Revenue by Countries
6.1 Europe Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2014-2019)
6.2 Germany Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
6.3 UK Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
6.4 France Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue by Countries
7.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2014-2019)
7.2 China Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
7.5 India Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
8 South America Chimeric Antigen Receptor Cell Therapy Revenue by Countries
8.1 South America Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2014-2019)
8.2 Brazil Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Chimeric Antigen Receptor Cell Therapy by Countries
9.1 Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
10 Global Chimeric Antigen Receptor Cell Therapy Market Segment by Type
10.1 Global Chimeric Antigen Receptor Cell Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global Chimeric Antigen Receptor Cell Therapy Market Forecast by Type (2019-2024)
10.3 Monotherapy Revenue Growth Rate (2014-2024)
10.4 Combination Therapy Revenue Growth Rate (2014-2024)
11 Global Chimeric Antigen Receptor Cell Therapy Market Segment by Application
11.1 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Application (2014-2019)
11.2 Chimeric Antigen Receptor Cell Therapy Market Forecast by Application (2019-2024)
11.3 Acute Leukemia Revenue Growth (2014-2019)
11.4 Non-hodgkin's Lymphoma Revenue Growth (2014-2019)
11.5 Multiple Myeloma Revenue Growth (2014-2019)
11.6 Transplant Rejection Revenue Growth (2014-2019)
11.7 Other Revenue Growth (2014-2019)
12 Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast (2019-2024)
12.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast (2019-2024)
12.2 Global Chimeric Antigen Receptor Cell Therapy Market Forecast by Regions (2019-2024)
12.3 North America Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2019-2024)
12.4 Europe Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2019-2024)
12.6 South America Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Chimeric Antigen Receptor Cell Therapy Picture
Table Product Specifications of Chimeric Antigen Receptor Cell Therapy
Table Global Chimeric Antigen Receptor Cell Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Types in 2018
Figure Monotherapy Picture
Figure Combination Therapy Picture
Table Global Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) by Application (2014-2024)
Figure Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Applications in 2018
Figure Acute Leukemia Picture
Figure Non-hodgkin's Lymphoma Picture
Figure Multiple Myeloma Picture
Figure Transplant Rejection Picture
Figure Other Picture
Table Global Market Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Table Amgen Inc Basic Information, Manufacturing Base and Competitors
Table Amgen Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Autolus Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Beijing Immunochina Medical Science & Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Bellicum Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Co Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table bluebird bio Inc Basic Information, Manufacturing Base and Competitors
Table bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table CARsgen Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Corp Basic Information, Manufacturing Base and Competitors
Table Celgene Corp Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Cell Medica Ltd Basic Information, Manufacturing Base and Competitors
Table Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Cellular Biomedicine Group Inc Basic Information, Manufacturing Base and Competitors
Table Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Celularity Inc Basic Information, Manufacturing Base and Competitors
Table Celularity Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Celyad SA Basic Information, Manufacturing Base and Competitors
Table Celyad SA Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Fosun Pharmaceutical AG Basic Information, Manufacturing Base and Competitors
Table Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Inc Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Guangzhou Anjie Biomedical Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Hangzhou Converd Co Ltd Basic Information, Manufacturing Base and Competitors
Table Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Hebei Senlang Biotechnology Inc Ltd Basic Information, Manufacturing Base and Competitors
Table Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table HRAIN Biotechnology Co Ltd Basic Information, Manufacturing Base and Competitors
Table HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Juno Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Kite Pharma Inc Basic Information, Manufacturing Base and Competitors
Table Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Nanjing Legend Biotech Co Ltd Basic Information, Manufacturing Base and Competitors
Table Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table NantKwest Inc Basic Information, Manufacturing Base and Competitors
Table NantKwest Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Nkarta Inc Basic Information, Manufacturing Base and Competitors
Table Nkarta Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Ono Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Sorrento Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Takara Bio Inc Basic Information, Manufacturing Base and Competitors
Table Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) by Players (2014-2019)
Table Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Players (2014-2019)
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Players in 2017
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Players in 2018
Figure Global Top 5 Players Chimeric Antigen Receptor Cell Therapy Revenue Market Share in 2018
Figure Global Top 10 Players Chimeric Antigen Receptor Cell Therapy Revenue Market Share in 2018
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Regions in 2018
Figure North America Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Europe Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure South America Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Table North America Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2014-2019)
Table North America Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries in 2018
Figure USA Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Canada Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Mexico Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Table Europe Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Europe Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries in 2018
Figure Germany Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure UK Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure France Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Russia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Italy Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries in 2018
Figure China Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Japan Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Korea Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure India Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Table South America Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2014-2019)
Table South America Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries in 2018
Figure Brazil Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Argentina Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Colombia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure UAE Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Egypt Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure South Africa Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs